Concepedia

Sheryl McCoy

SM

13

Publications

1.2K

Citations

11

H-Index

2003

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

SWOG Cancer Research Network

Cancer Research And Biostatistics

Saint Vincent Health System

Amgen (United States)

Sheryl McCoy is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

2003–2014

13

Publications

13

Phase II Trial of Erlotinib in Gastroesophageal Junction and Gastric Adenocarcinomas: SWOG 0127

Tomislav Dragovich, Sheryl McCoy, Cecilia M. Fenoglio‐Preiser et al. · Journal of Clinical Oncology · 2006 · 313 citations · Full text

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Giorgio V. Scagliotti, Ihor Vynnychenko, Keunchil Park et al. · Journal of Clinical Oncology · 2012 · 183 citations · Full text

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer: A Southwest oncology group (SWOG 9924) study

John S. Macdonald, Sheryl McCoy, Robert P. Whitehead et al. · Investigational New Drugs · 2005 · 148 citations

, , +7

Impact of Hospital Volume on Recurrence and Survival After Surgery for Gastric Cancer

Peter C. Enzinger, Jacqueline Benedetti, Jeffrey A. Meyerhardt et al. · Annals of Surgery · 2007 · 103 citations · Full text

Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133

Patricia A. Ganz, Carol M. Moinpour, Donna K. Pauler et al. · Journal of Clinical Oncology · 2003 · 99 citations

Rows per page

1–5 of 13